Gazioglu Nurperi, Ulu Mustafa Onur, Ozlen Fatma, Albayram Sait, Islak Civan, Kocer Naci, Oz Buge, Tanriover Necmettin, Yetkin Demet Ozgil, Gundogdu Sadi, Acbay Ozer, Kadioglu Pinar
Department of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
Clin Neurol Neurosurg. 2008 Apr;110(4):333-8. doi: 10.1016/j.clineuro.2007.11.008. Epub 2008 Mar 7.
The aim of this study was to determine the accuracy of bilateral cavernous sinus sampling (CSS) in preoperative tumor lateralization (right/left) within the pituitary in patients with Cushing's disease (CD).
The study consisted of 26 consecutive patients who had undergone CSS followed by transsphenoidal surgery (TS) for CD between 2000 and 2006 at our institution. The magnetic resonance imaging (MRI) of the selected patients either revealed a normal pituitary or a lesion <or=6mm within the gland. Simultaneous bilateral CSS with corticotropin releasing hormone (CRH) stimulation were performed in all cases and the data was analyzed in relation to the results of the MRI studies, intraoperative and pathological findings and the outcome.
Early remission was achieved in 23 patients (88%) and CSS predicted the correct localization of the adenoma in 22 patients (85%). No lateralization (elevated levels in both sides) was detected during CSS in two patients, due to lesions within the central part of the pituitary. In four cases, there was a false positive lateralization, in which no microadenoma could be located in the lateralized side of the pituitary, resulting in no remission. There were no complications related to the CSS.
CSS in CD seems to be a valuable and safe diagnostic tool, which can predict the correct location of the pituitary adenoma in 85% of the cases.
本研究旨在确定双侧海绵窦采样(CSS)在库欣病(CD)患者垂体术前肿瘤侧别判定(右侧/左侧)中的准确性。
本研究纳入了2000年至2006年间在我院连续接受CSS检查并随后接受经蝶窦手术(TS)治疗CD的26例患者。所选患者的磁共振成像(MRI)显示垂体正常或腺体内有≤6mm的病变。所有病例均进行了促肾上腺皮质激素释放激素(CRH)刺激下的双侧同步CSS,并根据MRI研究结果、术中及病理发现以及治疗结果对数据进行分析。
23例患者(88%)实现早期缓解,CSS对22例患者(85%)的腺瘤定位正确。2例患者因垂体中央部病变,CSS期间未检测到侧别差异(双侧水平均升高)。4例出现假阳性侧别差异,垂体侧别化一侧未发现微腺瘤,导致未缓解。CSS未出现相关并发症。
CD患者的CSS似乎是一种有价值且安全的诊断工具,在85%的病例中可预测垂体腺瘤的正确位置。